Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults living with chronic (long-term) pain
- People who have shown good adherence to their treatment plans
- People with severe, long-term difficulty sleeping (chronic insomnia)
- People for whom non-medication sleep therapies (such as sleep hygiene or talking therapies) have not worked
- People who have been taking zopiclone (a sleep medication) regularly for 3 months or longer
- People who are willing and able to keep a regular sleep diary
- People who are willing and able to keep a regular pain diary
- People who consent to having their diaries reviewed as part of the trial
- People who consent to having their clinical records reviewed for quality assurance purposes
Who may not be able to join:
- People who have obstructive sleep apnoea (a condition where breathing stops and starts during sleep)
- People with a Body Mass Index (BMI) of 40 or above
- People with significant problems affecting the function of major organs (such as the kidneys or liver)
- People with a cognitive disorder (a condition affecting memory, thinking, or understanding)
- People who are unable to give informed consent to participate
- People with a major mental health or neurological (brain and nervous system) condition
- People whose diaries are considered unreliable or incomplete
- People who use cannabis
- People who regularly drink alcohol
- People who use stimulants (substances that speed up the nervous system)
- People with a history of substance misuse or addiction
- People who have shown poor adherence to their treatment plans
- People who take high doses of opioid pain medications
- People who take gabapentinoids (a type of nerve pain medication, such as pregabalin or gabapentin)
- People who take other sedative (sleep-inducing) medications
- People whose insomnia is considered mild rather than severe
- People who take zopiclone irregularly rather than consistently
- People who have been taking zopiclone for less than 3 months
- People who have previously had a bad or allergic reaction to clonidine or zopiclone
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Olu Bamgbade, MD,FRCPC, Salem Anaesthesia Pain Clinic
Phone: +17786286600
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sleep quality score, objective measurement using the validated Likert sleep scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.